GAITHERSBURG, Md. and DEERFIELD, Ill., July 31, 2014 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau), and Walgreens (NYSE: WAG ) (Nasdaq: WAG ) today announced that, effective July 31, 2014, Walgreens Specialty Pharmacy will now serve as the exclusive specialty pharmacy provider for select Sigma-Tau prescription drugs, Adagen® (pegademase bovine), Cystaran® (cysteamine ophthalmic solution) and Matulane® (procarbazine hydrochloride). As a result of this agreement, each of these drugs can now be obtained through Walgreens Specialty Pharmacy locations.
"Through our integrated clinical and specialty distribution assets, we deliver comprehensive and collaborative patient care for those with complex conditions and are pleased to be able to better serve patients requiring these medications," said Mike Ellis, Walgreens corporate vice president, specialty and infusion pharmacy.
Dave Lemus, Chief Executive Officer of Sigma-Tau, noted, "We are very pleased to be able to work with Walgreens Specialty Pharmacy, whose broad reach will significantly improve our patients' ability to obtain their vitally needed medications. Through this cooperation, patients requiring Adagen®, Cystaran® or Matulane®, can feel secure that they will receive the highest quality service and responsiveness in managing their prescription and related healthcare needs."
Adagen®, Cystaran® and Matulane® are available at select Walgreens specialty, community and health system pharmacies.
For more information, call 877.534.9627 or visit www.walgreens.com/pharmacy/specialtypharmacy .
About Walgreens
As the nation's largest drugstore chain with fiscal 2013 sales of $72 billion, Walgreens ( www.walgreens.com ) vision is to be the first choice in health and daily living for everyone in America, and beyond. Each day, in communities across America, more than 8 million customers interact with Walgreens using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with online and mobile services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,217 drugstores in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Walgreens digital business includes Walgreens.com, drugstore.com, Beauty.com, SkinStore.com and VisionDirect.com. Take Care Health Systems is a Walgreens subsidiary that manages more than 400 in-store convenient care clinics throughout the country.
About Sigma-Tau Pharmaceuticals, Inc.
Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the sigma-tau Group, and is dedicated to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland, and the company's marketed products are focused on cancer, kidney disease, gastrointestinal and genetic related disorders. The company also has clinical development programs focused on hematological cancer, malaria, and other areas of unmet medical need. For more information about Sigma-Tau Pharmaceuticals, Inc., visit www.sigmatau.com .
| Contact at Sigma-Tau: | Contact for Sigma-Tau: | Contact at Walgreens: |
| Dave Lemus (CEO) | Eric Goldman | Markeisha Marshall |
| Sigma-Tau | Rx Communications Group, LLC | Walgreens |
| 301-670-1520 | 917-322-2563 | 847-315-2923 |
| dave.lemus@sigmatau.com | egoldman@RxIR.com | markeisha.marshall@walgreens.com |
